2m 2m 2m 2m 2m 2m 2m
ENCOMPASS HEALTH (EHC)
NYSE
$99.90+$1.22 (+1.24%)
Price as of Jun 23, 2026 7:04 PM EDT- $9.8BMarket Cap
- -17.37%1-Year Change
- Medical Care FacilitiesIndustry
ENCOMPASS HEALTH (EHC)
$99.90+$1.22 (+1.24%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.9B +10.46% | 5.4B +11.91% | 4.8B +10.41% | 4.3B -15.09% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 5.9B +10.46% | 5.4B +11.91% | 4.8B +10.41% | 4.3B -15.09% | |
Sales and Marketing Expense | 5.3M -8.62% | 5.8M -4.92% | 6.1M -3.17% | 6.3M +12.50% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 327.9M +9.45% | 299.6M +9.38% | 273.9M +12.44% | 243.6M -5.07% | |
Total Operating Expenses | 4.9B +8.28% | 4.5B +10.80% | 4.1B +9.44% | 3.7B -13.83% | |
Operating Profit | 953.0M +27.13% | 749.6M +23.45% | 607.2M +34.69% | 450.8M -31.41% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -143.5M -18.33% | -175.7M +6.74% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -143.5M -18.33% | -175.7M +6.74% | |
Total Nonoperating Income and Expense | 18.8M -6.47% | 20.1M +28.03% | 15.7M +401.92% | -5.2M -142.28% | |
Income before Taxes | 953.0M +27.13% | 749.6M +23.45% | 607.2M +34.69% | 450.8M -31.41% | |
Income Taxes | 192.9M +28.43% | 150.2M +13.62% | 132.2M +32.07% | 100.1M -28.30% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 566.2M +24.25% | 455.7M +29.46% | 352.0M +29.89% | 271.0M -34.26% | |
Net Income from Continuing Operations Applicable to Common | 567.2M +23.71% | 458.5M +25.96% | 364.0M +41.58% | 257.1M -37.69% | |
Basic EPS and Net Income | 5.62 +24.06% | 4.53 +29.06% | 3.51 +29.04% | 2.72 -34.46% | |
Diluted EPS and Net Income | 5.54 +24.22% | 4.46 +28.53% | 3.47 +28.52% | 2.70 -34.31% | |
Basic Weighted Average Shares | 100.5M +0.60% | 99.9M +0.40% | 99.5M +0.30% | 99.2M +0.20% | |
Diluted Weighted Average Shares | 102.2M 0.00% | 102.2M +0.89% | 101.3M +0.90% | 100.4M +0.20% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 72.2M -15.46% | 85.4M +23.59% | 69.1M +216.97% | 21.8M -60.22% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 72.2M -15.46% | 85.4M +23.59% | 69.1M +216.97% | 21.8M -60.22% | |
Total Current Assets | 905.9M +2.14% | 886.9M +5.36% | 841.8M +17.37% | 717.2M -22.16% | |
Accumulated Depreciation | 2.4B +12.35% | 2.1B +12.80% | 1.9B +12.82% | 1.7B +7.80% | |
Property and Plant and Equipment and Net | 4.1B +12.59% | 3.6B +10.36% | 3.3B +12.31% | 2.9B +12.98% | |
Total Long-Term Assets | 243.7M +11.18% | 219.2M +14.41% | 191.6M -13.69% | 222.0M -12.77% | |
Total Assets | 7.1B +8.49% | 6.5B +7.08% | 6.1B +8.27% | 5.6B -17.89% | |
Income Taxes Payable | 126.8M +20.53% | 105.2M +20.92% | 87.0M +4.82% | 83.0M -4.27% | |
Total Short-Term Debt | 43.6M -68.54% | 138.6M +458.87% | 24.8M -1.59% | 25.2M -41.12% | |
Total Current Liabilities | 836.4M -0.55% | 841.0M +28.12% | 656.4M +13.98% | 575.9M -23.09% | |
Total Long-Term Debt | 2.4B +3.73% | 2.4B -12.23% | 2.7B -1.97% | 2.7B -15.48% | |
Total Long-Term Liabilities | 53.8M +3.86% | 51.8M +12.36% | 46.1M +1.77% | 45.3M -8.30% | |
Total Liabilities | 3.8B +3.48% | 3.7B -3.15% | 3.8B +0.81% | 3.8B -15.48% | |
Retained Earnings | 1.3B +61.84% | 796.7M +95.99% | 406.5M +251.34% | 115.7M -18.41% | |
Total Stockholders Equity | 2.4B +17.96% | 2.1B +25.46% | 1.6B +25.73% | 1.3B -31.44% | |
Total Shares Outstanding | 116.0M 0.00% | 116.0M +0.54% | 115.4M +0.56% | 114.8M +0.49% | |
Cash Flow | |||||
Cash from Operating Activities | 1.2B +17.46% | 999.7M +19.75% | 834.8M +18.28% | 705.8M -1.40% | |
Capital Expenditures | 736.4M +14.61% | 642.5M +10.19% | 583.1M +3.24% | 564.8M +6.79% | |
Cash from Investing Activities | -764.6M +17.04% | -653.3M +8.38% | -602.8M -3.86% | -627.0M -5.90% | |
Dividends Paid | 71.1M +13.22% | 62.8M +3.97% | 60.4M -38.99% | 99.0M -11.92% | |
Cash from Financing Activities | -431.2M +30.43% | -330.6M +67.65% | -197.2M +35.35% | -145.7M -39.32% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 16.06% +15.10% | 13.95% +10.31% | 12.65% +22.00% | 10.37% -19.21% | |
Return on Assets | 8.31% +15.25% | 7.21% +20.26% | 6.00% +38.33% | 4.34% -30.00% | |
Return on Equity | 25.14% +2.44% | 24.54% +3.09% | 23.80% +41.47% | 16.82% -28.59% | |
Revenue Growth | 10.46% -12.21% | 11.91% +14.47% | 10.41% +168.96% | -15.09% -246.89% | |
Current Ratio | 1.08 +2.70% | 1.05 -17.76% | 1.28 +2.97% | 1.25 +1.21% | |
Cash Ratio | 0.09 -14.98% | 0.10 -3.61% | 0.11 +177.84% | 0.04 -48.22% | |
Debt-to-Equity Ratio | 1.02 -15.46% | 1.21 -26.61% | 1.65 -22.03% | 2.11 +22.80% | |
Debt-to-Assets Ratio | 0.35 -8.08% | 0.38 -14.02% | 0.44 -9.45% | 0.49 +2.53% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow